Xylazine classified as a Schedule III controlled substance - Ohio's Country Journal
Xylazine classified as a Schedule III controlled substance - Ohio's Country Journal — schedule update affecting Pharmacy & Controlled Substances.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 8, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmacy & Controlled Substances (independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies) should confirm how it applies to their specific situation before acting. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmacy & Controlled Substances move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
Xylazine classified as a Schedule III controlled substance - Ohio's Country Journal
Who it affects
Pharmacy & Controlled Substances (independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies)
What you must do
Read the update and assess whether your current setup needs to change.
Deadline
No fixed deadline was published, but changes like this are often enforced quickly — act promptly.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Mail-order dominates US abortion pill dispensing - reuters.com
- Pharmacies begin dispensing abortion pills - politico.com
- Telehealth Reforms Could Expand Access to Health Care in Louisiana - reason.org
- Kansas regulators issue statement following complaints of retail IV therapy clinics - kshb.com
- Modernizing addiction regulations: How licensing, telehealth, and delivery reform can expand access to care - reason.org